XETRA · MRK.DE
Merck KGaA
€150.30+€4.25 (+2.91%)
Merck KGaA’s quoted price sits in the upper half of its reported 52-week range, 0.86% below the high.
Loading market information…
XETRA · GXI.DE · EUR
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 04:35 PM UTC. Cached market data; not a live quote.
One-year closing-price history · EUR. Historical prices are not a forecast.
Gerresheimer AG’s quoted price sits in the upper half of its reported 52-week range, 6.73% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Gerresheimer AG’s forward annual dividend is €0.04 per share, paid annual. The forward yield is 0.13% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Gerresheimer AG’s next earnings report is currently expected on Nov 4, 2026, with estimated earnings per share of €0.26. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Gerresheimer AG’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Gerresheimer AG, founded in 1864 and based in Düsseldorf, Germany, is a global supplier specializing in the production and sale of packaging solutions and sophisticated drug delivery systems. The company operates through three distinct divisions. Its Plastics & Devices segment provides a variety of drug administration tools, such as inhalers, insulin pen systems, prefillable syringes, and diagnostic systems, for the pharmaceutical, biotech, diagnostics, and medical technology sectors. This division also manufactures plastic containers, closures, PET bottles, eye droppers, nasal sprays, nebulizers, applicators, and related accessories for solid, liquid, and ophthalmic applications, alongside bottles for nutritional supplements. The Primary Packaging Glass division offers glass primary packaging products for the pharmaceutical and cosmetics industries, including infusion, dropper, and syrup bottles; injection vials, ampoules, and cartridges; and miniature bottles for liquid food, spices, spirits, fragrances, deodorants, skincare, and wellness products. Lastly, the Advanced Technologies division focuses on developing intelligent drug delivery systems, like micro pumps, designed to enable the self-administration of medication for conditions such as Parkinson's disease or heart failure, serving its pharmaceutical and biotech clients.
Latest available per-share figures in EUR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:33 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q1 2025 |
|---|
| Apr 8, 2025 |
| €0.46+93.52% vs estimate |
| €520.10M-0.57% vs estimate |
| Q4 2024 | Feb 26, 2025 | €1.63+12.41% vs estimate | €568.90M-0.77% vs estimate |
|---|
| Q3 2024 | Oct 10, 2024 | €1.16-0.85% vs estimate | €498.50M-0.07% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
€150.30+€4.25 (+2.91%)
Merck KGaA’s quoted price sits in the upper half of its reported 52-week range, 0.86% below the high.
€42.89+€0.30 (+0.7%)
Siemens Healthineers AG’s quoted price sits in the upper half of its reported 52-week range, 13.7% below the high.
€47.96+€1.93 (+4.19%)
Bayer Aktiengesellschaft’s quoted price sits in the upper half of its reported 52-week range, 11.05% below the high.
€298.50+€6.00 (+2.05%)
Sartorius AG’s quoted price sits in the upper half of its reported 52-week range, 0.27% below the high.
€25.10-€0.40 (-1.57%)
SCHOTT Pharma AG & Co. KGaA’s quoted price sits in the upper half of its reported 52-week range, 3.83% below the high.
€105.40+€0.80 (+0.76%)
Drägerwerk AG & Co. KGaA’s quoted price sits in the upper half of its reported 52-week range, 15.95% below the high.
€13.22-€0.08 (-0.6%)
Eckert & Ziegler SE’s quoted price sits in the lower half of its reported 52-week range, 24.33% below the high.
€22.75-€0.15 (-0.66%)
Stratec SE’s quoted price sits in the upper half of its reported 52-week range, 14.31% below the high.
